Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ENDRA Life Sciences (NDRA) Other Operating Expenses (2016 - 2025)

ENDRA Life Sciences has reported Other Operating Expenses over the past 6 years, most recently at $382113.0 for Q4 2021.

  • Quarterly Other Operating Expenses rose 98.58% to $382113.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2021, up 84.81% year-over-year, with the annual reading at $189470.0 for FY2025, 66.82% down from the prior year.
  • Other Operating Expenses was $382113.0 for Q4 2021 at ENDRA Life Sciences, up from $275565.0 in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $382113.0 in Q4 2021 and troughed at $1124.0 in Q1 2017.
  • The 5-year median for Other Operating Expenses is $111066.0 (2018), against an average of $137124.4.
  • Year-over-year, Other Operating Expenses soared 9435.32% in 2018 and then crashed 72.14% in 2019.
  • A 5-year view of Other Operating Expenses shows it stood at $67201.0 in 2017, then crashed by 37.61% to $41928.0 in 2018, then soared by 298.47% to $167070.0 in 2019, then rose by 15.18% to $192424.0 in 2020, then soared by 98.58% to $382113.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Other Operating Expenses are $382113.0 (Q4 2021), $275565.0 (Q3 2021), and $256763.0 (Q2 2021).